THE SCIENCE OF CHARIOT

The world of Multiple Sclerosis has seen dramatic changes:

​

MS is now no longer seen as three seperate diseases but one.

​

The inflammation behind disability is establised as occuring long before the first signs of the disease and is known to be still active to the very last day

​

Insights into the critical role of B cells and the precise nature of inflammation has led to an understanding of Slowly Evolving Lesions and a potential role for the EBV virus.

​

Over 19 drugs now have a UK licence

to modify the course of MS disease and mitigate relapses.

​

However, not everyone with MS has seen changes to their treatment.

​

This trial is about those people.